Ovarian Reserve

N. S. Macklon; B. C. J. M. Fauser

doi:10.1055/s-2005-872453

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2005; 23(3): 248-256
DOI: 10.1055/s-2005-872453

Ovarian Reserve

N. S. Macklon¹ , B.C.J. M. Fauser²

¹Professor, Head Infertility, Department of Gynaecology and Reproductive Medicine, University Medical Centre, Utrecht, The Netherlands
²Professor, Head, Department of Reproductive Medicine, Chair, Division of Perinatology and Gynecology, University Medical Centre, Utrecht, The Netherlands

Abstract

ABSTRACT

The tendency to delay childbirth has increased the importance of ovarian reserve as a determinant of infertility treatment outcome. In the context of assisted reproduction technology, effective strategies to overcome the impact of ovarian aging and diminished ovarian reserve on pregnancy chances remain elusive. Markers of ovarian reserve are increasingly used to aid management and counseling of these patients. Proper interpretation of currently applied hormonal markers, ultrasound parameters, and hormone challenge tests requires an understanding of what constitutes and determines ovarian reserve. This article addresses these aspects and highlights recent developments in the field.

KEYWORDS

Ovarian reserve - ovarian aging - assisted reproduction - follicle-stimulating hormone - antral follicle count

Full Text

References

REFERENCES

1 Evers J L. Female subfertility. Lancet. 2002; 360 151-159
2 Baker T C. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond Br Biol Sci. 1963; 158 417-433
3 Forabasco A, Sforza C, de Pol A, Vizzotto L, Marzona L. Morphometric study of the human neonatal ovary. Anat Rec. 1991; 231 201-208
4 Himelstein-Braw R, Byskov A G, Peters H, Faber M. Follicular atresia in the infant human ovary. J Reprod Fertil. 1976; 46 455-459
5 Faddy M J, Gosden R G, Gougeon A, Richardson S J, Nelson J F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992; 7 1342-1346
6 Schwartzman R A, Cidlowski J. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev. 1993; 14 133-151
7 Lintern-Moore S, Peters H, Moore G P, Faber M. Follicular development in the infant human ovary. J Reprod Fertil. 1974; 39 53-64
8 Johnson J, Canning J, Kaneko T, Pru J K, Tilly J L. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428 145-150
9 Treloar A E. Menstrual cyclicity and the premenopause. Maturitas. 1981; 3 49-64
10 Scott R T, Toner J P, Muasher S J, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989; 51 651-654
11 Klein N A, Battaglia D E, Fujimoto V Y. Reproductive aging: accelerated ovarian follicular development associated with a monotropic rise in follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab. 1996; 81 1038-1045
12 te Velde E R, Pearson P L. The variability of female reproductive ageing. Hum Reprod Update. 2002; 8 141-154
13 Piette C, de Mouzon J, Bachelot A, Spira A. In-vitro fertilization: influence of women's age on pregnancy rates. Hum Reprod. 1990; 5 56-59
14 Tucker M J, Morton P C, Wright G, Ingargiola P E, Jones A E, Sweitzer C L. Factors affecting success with intracytoplasmic sperm injection. Reprod Fertil Dev. 1995; 7 229-236
15 Ashkenazi J, Orvieto R, Gold-Deutch R et al.. The impact of woman’s age and sperm parameters on fertilization rates in IVF cycles. Eur J Obstet Gynecol Reprod Biol. 1996; 66 155-159
16 Yie S M, Collins J A, Daya S, Hughes E, Sagle M, Younglie E V. Polyploidy and failed fertilization in in-vitro fertilization are related to patients age and gamete quality. Hum Reprod. 1996; 11 614-617
17 Cordiero I, Calhaz-Jorge C, Barata M, Leal F, Proenca H, Coelho A M. Repercussao da idade de mulher, de taxa de clivagem e da qualidade embrionaria, na obtencao de graviez por fertilizacao in-vitro. Acta Med Port. 1995; 8 145-150
18 Hull M G, Fleming C F, Hughes A O, McDermott A. The age related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in-vitro fertilization. Fertil Steril. 1996; 65 783-790
19 Sharif K, Elgendy M, Lashen H, Afnan M. Age and basal follicle stimulating hormone as predictors of in vitro fertilization outcome. Br J Obstet Gynaecol. 1998; 105 107-112
20 Yaron Y, Botchan A, Amit A et al.. Endometrial receptivity: the age related decline in pregnancy rates and the effect of ovarian function. Fertil Steril. 1993; 60 314-318
21 Roest J, Van Heusden A M, Mous H, Zeilmaker G H, Verhoeff A. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil Steril. 1996; 66 969-973
22 Widra E A, Botchan A, Amit A, Kogosowaki A, Yovel I, Lessing J B. Endometrial receptivity: the age-related decline in pregnancy rates and the effect of ovarian function. Fertil Steril. 1996; 65 103-108
23 Legro R S, Shakleworth D P, Moessner J M, Gnatuk C L, Dodson W C. ART in women 40 and over. Is the cost worth it?. J Reprod Med. 1997; 42 76-82
24 van Noord-Zaadstra B M, Looman C W, Alsbach H, Habbema J D, te Velde E R, Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ. 1991; 302 1361-1365
25 Templeton A A, Morris J K, Parslow W. Factors that affect the outcome of in vitro fertilization treatment. Lancet. 1996; 348 1402-1406
26 Chuang C C, Chen C D, Chao K H, Chen S U, Ho H N, Yang Y S. Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril. 2003; 79 63-68
27 Fauser B CJM, Macklon N S. Medical approaches to ovarian stimulation for infertility. In: Strauss JF, Barbieri RL Yen and Jaffe's Reproductive Endocrinology. 5th ed. Philadelphia, PA; Elsevier Saunders 2004: 965-1012
28 de Boer E J, den Tonkelaar I, te Velde E R, Burger C W, Klip H, van Leeuwen F E. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril. 2002; 77 978-985
29 Nikolaou D, Lavery S, Turner C, Margara R, Trew G. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?. Hum Reprod. 2002; 17 1106-1111
30 Lawson R, El-Toukhy T, Kassab A et al.. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod. 2003; 18 527-533
31 Tarlatzis B C, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003; 9 61-76
32 Van Hooff M H, Alberda A T, Huisman G J, Zeilmaker G H, Leerentveld R A. Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod. 1993; 8 369-373
33 Out H J, Braat D D, Lintsen B M et al.. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod. 2000; 15 29-35
34 Keny S. The poor responed. In: Macklon N NF in One Medically Complicated Patient: A Guide to Management London; Taylor and Francis 2005: 205-219
35 Muasher S J, Oehninger S, Simonetti S et al.. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril. 1988; 50 298-307
36 Toner J P, Philput C B, Jones G S, Muasher S J. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991; 55 784-791
37 Akande V A, Fleming C F, Hunt L P, Keay S D, Jenkins J M. Biological versus chronological ageing in oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod. 2002; 17 2003-2008
38 van Rooij I A, Bancsi L F, Broekmans F J, Looman C W, Habbema J D, te Velde E R. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril. 2003; 79 482-488
39 Toner J P. Modest follicle-stimulating hormone elevations in younger women: warn but don’t disqualify. Fertil Steril. 2004; 81 1493-1495
40 Scott Jr R T, Hofmann G E. Prognostic assessment of ovarian reserve. Fertil Steril. 1995; 63 1-11
41 Bancsi L F, Broekmans F J, Mol B W, Habbema J D, te Velde E R. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril. 2003; 79 1091-1100
42 van Rooij I AJ, de Jong E, Broekmans F JM et al.. High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril. 2004; 81 1478-1485
43 Schipper I, de Jong F H, Fauser BCJM. Lack of correlation between maximum early follicular phase serum follicle-stimulating hormone levels and menstrual cycle characteristics in women under the age of 35. Hum Reprod. 1998; 13 1442-1448
44 Martin JSB, Nisker J A, Tummon I S et al.. Future in vitro fertilization pregnancy potential of women with variable elevated day 3 follicle-stimulating hormone levels. Fertil Steril. 1996; 65 1238-1240
45 Scott R T, Hofmann G E, Oehninger S C, Muasher S J. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril. 1990; 54 297-302
46 Evers J L, Slaats P, Land J A, Dumoulin J C, Dunselman G A. Elevated levels of basal estradiol-17 beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril. 1998; 69 1010-1014
47 Lockwood G M. Prognostic tests of ovarian reserve. In: Gardner DK, Weissman A, Howles CM, Shoham Z Textbook of Assisted Reproductive Techniques. 2nd ed. London; Taylor and Francis 2004: 781-787
48 Groome N P, Illingworth P J, O'Brien M et al.. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996; 81 1401-1405
49 Creus M, Penarrubia J, Fabregues F et al.. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod. 2000; 15 2341-2346
50 Yong P Y, Baird D T, Thong K J, McNeilly A S, Anderson R A. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod. 2003; 18 35-44
51 Klein N A, Illingworth P J, Groome N P, McNeilly A S, Battaglia D E, Soules M R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab. 1996; 81 2742-2745
52 Seifer D B, Lambert-Messerlian G, Hogan J W, Gardiner A C, Blazar A S, Berk C A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril. 1997; 67 110-114
53 Seifer D B, Scott Jr R T, Bergh P A et al.. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril. 1999; 72 63-65
54 Hall J E, Welt C K, Cramer D W. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod. 1999; 14 409-415
55 Corson S L, Gutmann J, Batzer F R, Wallace H, Klein N, Soules M R. Inhibin-B as a test of ovarian reserve for infertile women. Hum Reprod. 1999; 14 2818-2821
56 Penarrubia J, Balasch J, Fabregues F et al.. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod. 2000; 15 1499-1504
57 Fawzy M, Lambert A, Harrison R F et al.. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum Reprod. 2002; 17 1535-1543
58 Bancsi L F, Broekmans F J, Eijkemans M J, de Jong F H, Habbema J D, te Velde E R. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002; 77 328-336
59 Reuss M L, Kline J, Santos R. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol. 1996; 174 624-627
60 Fratterelli J L, Levi A J, Miller B T, Segars J H. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril. 2003; 80 350-355
61 Andolf A, Jorgensen C, Svalenius E et al.. Ultrasound measurement of the ovarian volume. Acta Obstet Gynecol Scand. 1987; 66 387-389
62 Syrop C H, Willhoite A, van Voorhuis B J. Ovarian volume: a novel outcome predictor for assisted reproduction. Fertil Steril. 1995; 64 1167-1171
63 Lass A, Skull J, McVeigh E, Margara R, Winston R M. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod. 1997; 12 294-297
64 Syrop C H, Dawson J D, Husman K J et al.. Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod. 1999; 14 1752-1756
65 Navot D, Rosenwaks Z, Mergalioth E J. Prognostic assessment of female fecundity. Lancet. 1987; 2 645-647
66 Bukman A, Heineman M J. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update. 2001; 7 581-590
67 Sharara F I, Scott R T, Seifer D B. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol. 1998; 179 804-812
68 Jain T, Soules M R, Collins J. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril. 2004; 82 180-185
69 Fanchin R, de Ziegler D, Olivennes F et al.. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‘poor responders’ in in-vitro fertilization. Hum Reprod. 1994; 9 1607-1611
70 Kwee J, Schats R, McDonnell J, Lambalk C B, Schoemaker J. Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod. 2004; 19 590-595
71 Padilla S L, Bayati J, Garcia J E. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril. 1990; 53 288-294
72 De Vet A, Laven J S, de Jong F H, Themmen A P, Fauser B C. Anti-mullerian hormone serum hormone levels: a putative marker for ovarian aging. Fertil Steril. 2002; 77 357-362
73 Fanchin R, Schonauer L M, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003; 18 323-327
74 Seifer D B, MacLaughlin D T, Christian B P, Feng B, Shelden R M. Early follicular serum mullerian-inhibiting levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002; 77 468-471
75 van Rooij I A, Broekmans F J, te Velde E R et al.. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002; 17 3065-3071
76 Beckers N G, Macklon N S, Eijkemans M J, Fauser B C. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril. 2002; 78 291-297
77 Hohmann F P, Macklon N S, Fauser B C. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard longGnRH agonist protocol. J Clin Endocrinol Metab. 2003; 88 166-173
78 Bath L E, Wallace W H, Shaw M P, Fitzpatrick C, Anderson R A. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003; 18 2368-2374

Prof.
N. S Macklon

Department of Gynecology and Reproductive Medicine, University Medical Centre

Utrecht, Heidelberglaan 100

3584 CX Utrecht, The Netherlands

Email: n.macklon@umcutrecht